Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2012

Feb 8, 2012

29777_dirs_2012-02-07_de3dd545-8ad1-468b-bb9a-036aa3483189.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-02-03

Reporting Person: Michael Edward L (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-02-03 Common shares without par value M 51311 $53.625 Acquired 258761 Direct
2012-02-03 Common shares without par value S 42511 $55 Disposed 216250 Direct
2012-02-03 Common shares without par value S 200 $55.005 Disposed 216050 Direct
2012-02-03 Common shares without par value S 4800 $55.01 Disposed 211250 Direct
2012-02-03 Common shares without par value S 100 $55.0125 Disposed 211150 Direct
2012-02-03 Common shares without par value S 1500 $55.015 Disposed 209650 Direct
2012-02-03 Common shares without par value S 2200 $55.02 Disposed 207450 Direct
2012-02-06 Common shares without par value M 1890 $53.625 Acquired 209340 Direct
2012-02-06 Common shares without par value F 1842 $55.00 Disposed 207498 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-03 Option (right to buy) $53.625 M 51311 Disposed 2012-02-14 Common shares (51311) Direct
2012-02-06 Option (right to buy) $53.625 M 1890 Disposed 2012-02-14 Common shares (1890) Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.